← Eichor
Condition: Transformed Small Cell Lung Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Transformed Small Cell Lung Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizum
Phase 2 · 1 location(s) · Se-Hoon Lee · NCT06830694Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult
Phase 2 · 12 location(s) · Pfizer · NCT07476287A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · 17 location(s) · Nurix Therapeutics, Inc. · NCT05107674Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC
Phase N/A · 1 location(s) · Fudan University · NCT06369181Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer
Phase 1/Phase 2 · 1 location(s) · Misty Shields · NCT07153055
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.